HOME >> MEDICINE >> NEWS
Blocking enzyme found to ease anxiety without causing sedation

The trouble with most anti-anxiety drugs is that they tend to sedate, not just relax. A research team led by scientists at UCSF's Ernest Gallo Clinic and Research Center has shown that de-activating a common enzyme in neurons reduces anxiety without inducing sedation. The study in mice suggests a new route to treat anxiety while avoiding sedating and possibly addicting effects.

The research, published in the October issue of The Journal of Clinical Investigation, also showed that blocking the enzyme reduced levels of stress hormones. The same issue of the journal includes a commentary on the research (Anxiolytic Drug Targets: Beyond the Usual Suspects) by Joshua A. Gordon of Columbia University's Center for Neurobiology and Behavior.

Anti-anxiety drugs such as Valium often leave people sedated, less capable at mental tasks, and can become addicting, whereas drugs without these side effects -- such as some antidepressants -- may not reduce anxiety as well, said Robert Messing, MD, UCSF professor of neurology at the Gallo Research Center and senior author on the paper.

But in the new study, mice lacking the enzyme showed reduced anxiety while maintaining normal levels of alertness and learning abilities, the researchers reported.

The enzyme, known as protein kinase C epsilon (PKC epsilon), is present in many neurons in the brain, but its role is not well known. Its ability to affect anxiety but not sedation may stem from indirect, rather than direct action, the researchers found.

When the neurotransmitter GABA binds to proteins on the surface of many neurons, known as GABA-A receptors, the neurons become less active, which tends to reduce anxiety. Drugs such as Valium act by increasing the action of GABA at the GABA-A receptors. A group of brain molecules derived from progesterone, known as neurosteroids, also act to increase the action at the GABA-A receptor, and thereby reduce anxiety. But PKC epsilon appears to make the GA
'"/>

Contact: Wallace Ravven
wravven@pubaff.ucsf.edu
415 476-2557
University of California - San Francisco
2-Oct-2002


Page: 1 2

Related medicine news :

1. Blocking molecules protects health of implants
2. Blocking selected neurotransmitter activity may decrease alcohol consumption
3. Blocking immune response to spinal cord injury can improve chances for recovery
4. Blocking pathway overcomes tumor vessel resistance to radiation
5. Blocking adhesion protein may reduce lung damage from radiation
6. Blocking gene may reduce lung scarring caused by radiation therapy
7. Scientists discover enzyme crucial to the transportation of proteins within cells
8. Scientists discover enzyme crucial to HIV replication
9. Study shows coenzyme Q10 may prevent migraine
10. New information about heart enzymes could lead to better treatments
11. Researchers identify enzyme that may turn fleeting experience into lasting memory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/30/2020)... ... May 29, 2020 , ... Segal Trials, a privately held ... trials, commemorated May, Mental Health Awareness Month, and May 20th, Clinical Trial Awareness ... Efforts include their #StayConnected video series raising awareness of clinical trials and offering ...
(Date:5/28/2020)... ... May 28, 2020 , ... ... is joining the clinically integrated network (CIN) and the group purchasing organization run ... Cardiovascular Institute to establish a heart failure program at Mon Health Medical Center. ...
(Date:5/27/2020)... N.J. (PRWEB) , ... May 27, 2020 , ... ... manufacturer, announces that it is now manufacturing face shields to be used ... coronavirus that causes COVID-19. These face shields are single use, made to be ...
(Date:5/27/2020)... ... May 27, 2020 , ... ... University of Washington Professor of Bioengineering, Founder & Editor of scientific journal ... Vapor ( https://www.amazon.com/Fourth-Phase-Water-Beyond-Liquid-ebook/dp/B00N2ASKF2 ) , https://www.voiceamerica.com/episode/123059/the-fourth-phase-of-water , * , ...
(Date:5/26/2020)... Mass. (PRWEB) , ... May 26, 2020 , ... Today ... Self-Assessment , a free online tool that will help business owners and leaders assess ... reopen and ramp up. This latest offering from TRC is intended to assist business ...
Breaking Medicine News(10 mins):
(Date:6/4/2020)... ... June 04, 2020 , ... One minute it was business as usual, ... the lexicon. COVID-19 turned the world on its head, and everything ground to a ... AutismOne annual conference went from a physical event to a virtual one in seven ...
(Date:6/3/2020)... ... June 03, 2020 , ... Axiom Medical, a longtime leader ... CheckIn2Work app, a first of its kind technology providing workplace point-of-entry protection and ... quick and easy self-service health attestation for organizations needing to pre-screen team members ...
(Date:6/2/2020)... ... June 02, 2020 , ... ... of cancers with the watershed FDA approvals of two Chimeric Antigen Receptor T-Cell ... have emerged including modified T-cell receptor T-cells (TCR-Ts), Natural Killer (NKs) cells and ...
Breaking Medicine Technology:
Cached News: